| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, Emission-Computed, Single-Photon | 37 | 2013 | 1068 | 3.490 |
Why?
|
| Radiopharmaceuticals | 48 | 2014 | 2650 | 2.670 |
Why?
|
| Radionuclide Imaging | 75 | 2011 | 1972 | 2.340 |
Why?
|
| Technetium Tc 99m Medronate | 19 | 2010 | 131 | 2.110 |
Why?
|
| Technetium Tc 99m Dimercaptosuccinic Acid | 18 | 2012 | 81 | 2.050 |
Why?
|
| Radioisotope Renography | 7 | 2011 | 61 | 1.220 |
Why?
|
| Organotechnetium Compounds | 17 | 2013 | 129 | 1.100 |
Why?
|
| Nuclear Medicine | 6 | 2014 | 237 | 1.070 |
Why?
|
| Radiation Dosage | 17 | 2014 | 1956 | 0.930 |
Why?
|
| Vesico-Ureteral Reflux | 16 | 2011 | 437 | 0.880 |
Why?
|
| 3-Iodobenzylguanidine | 3 | 2013 | 114 | 0.870 |
Why?
|
| Kidney | 17 | 2012 | 7045 | 0.760 |
Why?
|
| Positron-Emission Tomography | 17 | 2014 | 6483 | 0.750 |
Why?
|
| Neuroblastoma | 6 | 2013 | 1248 | 0.710 |
Why?
|
| Fractures, Stress | 6 | 2004 | 202 | 0.700 |
Why?
|
| Low Back Pain | 4 | 2013 | 982 | 0.680 |
Why?
|
| Thallium Radioisotopes | 6 | 1999 | 138 | 0.600 |
Why?
|
| Fluorodeoxyglucose F18 | 9 | 2014 | 2008 | 0.580 |
Why?
|
| Bone and Bones | 11 | 2007 | 2565 | 0.570 |
Why?
|
| Pyelonephritis | 5 | 2001 | 75 | 0.570 |
Why?
|
| Fluorine Radioisotopes | 4 | 2012 | 418 | 0.560 |
Why?
|
| Gallium Radioisotopes | 4 | 2007 | 195 | 0.550 |
Why?
|
| Iridium | 5 | 2004 | 30 | 0.550 |
Why?
|
| Tomography, Emission-Computed | 6 | 2011 | 1122 | 0.550 |
Why?
|
| Athletic Injuries | 5 | 2013 | 1216 | 0.540 |
Why?
|
| Body Burden | 5 | 2012 | 158 | 0.510 |
Why?
|
| Bone Neoplasms | 14 | 2007 | 2527 | 0.510 |
Why?
|
| Pediatrics | 7 | 2012 | 3588 | 0.510 |
Why?
|
| Technetium Tc 99m Pentetate | 6 | 1999 | 67 | 0.500 |
Why?
|
| Kidney Cortex | 4 | 2001 | 169 | 0.490 |
Why?
|
| Child | 97 | 2014 | 80079 | 0.480 |
Why?
|
| Technetium Tc 99m Mertiatide | 3 | 2011 | 21 | 0.480 |
Why?
|
| Kidney Diseases | 7 | 2012 | 2090 | 0.460 |
Why?
|
| Choristoma | 5 | 2001 | 205 | 0.450 |
Why?
|
| Sacrum | 3 | 2004 | 274 | 0.430 |
Why?
|
| Radiation Protection | 4 | 2012 | 424 | 0.420 |
Why?
|
| Osteoma, Osteoid | 5 | 2001 | 90 | 0.400 |
Why?
|
| Copper Radioisotopes | 5 | 2010 | 91 | 0.390 |
Why?
|
| Urinary Bladder | 6 | 1997 | 1151 | 0.390 |
Why?
|
| Osteomyelitis | 7 | 2003 | 407 | 0.380 |
Why?
|
| Infant | 52 | 2014 | 36152 | 0.380 |
Why?
|
| Radiotherapy | 2 | 2011 | 1497 | 0.370 |
Why?
|
| Organometallic Compounds | 6 | 2002 | 646 | 0.370 |
Why?
|
| Sodium Fluoride | 2 | 2007 | 65 | 0.360 |
Why?
|
| Kidney Pelvis | 4 | 2012 | 186 | 0.360 |
Why?
|
| Child, Preschool | 53 | 2014 | 42188 | 0.360 |
Why?
|
| Technetium Tc 99m Sulfur Colloid | 4 | 2000 | 63 | 0.350 |
Why?
|
| Tibia | 4 | 2001 | 1069 | 0.350 |
Why?
|
| Tibial Fractures | 3 | 2004 | 272 | 0.350 |
Why?
|
| Lung Diseases | 5 | 2011 | 1909 | 0.340 |
Why?
|
| Spinal Injuries | 1 | 2013 | 300 | 0.340 |
Why?
|
| Image Interpretation, Computer-Assisted | 4 | 2011 | 3356 | 0.330 |
Why?
|
| Radiometry | 4 | 2012 | 812 | 0.310 |
Why?
|
| Ureter | 3 | 2001 | 368 | 0.310 |
Why?
|
| Musculoskeletal System | 1 | 2010 | 188 | 0.310 |
Why?
|
| Osmium | 3 | 1999 | 18 | 0.300 |
Why?
|
| Pleural Neoplasms | 2 | 2003 | 609 | 0.300 |
Why?
|
| Phantoms, Imaging | 6 | 2012 | 2518 | 0.300 |
Why?
|
| Succimer | 5 | 1995 | 31 | 0.300 |
Why?
|
| Femur | 4 | 2007 | 1307 | 0.300 |
Why?
|
| Sports Medicine | 1 | 2010 | 239 | 0.300 |
Why?
|
| Radioisotopes | 8 | 2007 | 499 | 0.290 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2011 | 549 | 0.290 |
Why?
|
| Germanium | 1 | 2007 | 7 | 0.290 |
Why?
|
| Cysteine | 3 | 1996 | 891 | 0.280 |
Why?
|
| Mandible | 2 | 2009 | 753 | 0.280 |
Why?
|
| Adolescent | 56 | 2014 | 88234 | 0.270 |
Why?
|
| Mesothelioma | 2 | 2003 | 807 | 0.270 |
Why?
|
| Renal Circulation | 3 | 2004 | 291 | 0.270 |
Why?
|
| Epilepsy | 7 | 2011 | 3288 | 0.250 |
Why?
|
| Musculoskeletal Diseases | 2 | 2011 | 597 | 0.250 |
Why?
|
| Humans | 162 | 2014 | 760617 | 0.250 |
Why?
|
| Heart | 9 | 2012 | 4403 | 0.250 |
Why?
|
| Osteosarcoma | 4 | 2001 | 896 | 0.250 |
Why?
|
| Tomography, X-Ray Computed | 14 | 2012 | 20556 | 0.250 |
Why?
|
| Body Weight | 4 | 2012 | 4614 | 0.250 |
Why?
|
| Lumbar Vertebrae | 3 | 2004 | 1874 | 0.240 |
Why?
|
| Oximes | 7 | 1996 | 303 | 0.240 |
Why?
|
| Back Pain | 2 | 2007 | 545 | 0.230 |
Why?
|
| Bone Diseases | 3 | 1999 | 418 | 0.230 |
Why?
|
| Kidney Papillary Necrosis | 1 | 2003 | 3 | 0.230 |
Why?
|
| Image Enhancement | 4 | 2010 | 2881 | 0.230 |
Why?
|
| Ureteral Obstruction | 4 | 2012 | 293 | 0.220 |
Why?
|
| Nurses | 1 | 2013 | 2477 | 0.220 |
Why?
|
| Epiphyses, Slipped | 1 | 2003 | 87 | 0.220 |
Why?
|
| Bone Cysts, Aneurysmal | 1 | 2003 | 70 | 0.210 |
Why?
|
| Female | 97 | 2014 | 392148 | 0.210 |
Why?
|
| Technetium Tc 99m Disofenin | 2 | 2001 | 13 | 0.210 |
Why?
|
| Rectus Abdominis | 1 | 2003 | 103 | 0.210 |
Why?
|
| Gastrointestinal Diseases | 1 | 2011 | 1201 | 0.210 |
Why?
|
| Pattern Recognition, Automated | 1 | 2009 | 994 | 0.210 |
Why?
|
| Dose-Response Relationship, Radiation | 4 | 2011 | 880 | 0.210 |
Why?
|
| Lymphoma | 1 | 2011 | 1899 | 0.200 |
Why?
|
| Diagnostic Imaging | 4 | 2011 | 3527 | 0.200 |
Why?
|
| Gamma Cameras | 4 | 2003 | 34 | 0.200 |
Why?
|
| Hydronephrosis | 3 | 2003 | 271 | 0.190 |
Why?
|
| Myocardial Perfusion Imaging | 3 | 2012 | 575 | 0.190 |
Why?
|
| Brain Neoplasms | 7 | 2014 | 9026 | 0.190 |
Why?
|
| Calcaneus | 1 | 2003 | 142 | 0.190 |
Why?
|
| Radionuclide Generators | 3 | 1999 | 12 | 0.190 |
Why?
|
| Male | 86 | 2014 | 360358 | 0.190 |
Why?
|
| Leg Bones | 1 | 2001 | 19 | 0.190 |
Why?
|
| Specialty Boards | 1 | 2003 | 235 | 0.190 |
Why?
|
| Foot Bones | 1 | 2001 | 23 | 0.190 |
Why?
|
| Magnetic Resonance Imaging | 20 | 2014 | 36402 | 0.190 |
Why?
|
| Caregivers | 1 | 2013 | 2241 | 0.190 |
Why?
|
| Sensitivity and Specificity | 10 | 2013 | 14648 | 0.180 |
Why?
|
| Rhodamines | 2 | 2012 | 178 | 0.180 |
Why?
|
| Phenylacetates | 1 | 2000 | 112 | 0.180 |
Why?
|
| Osteoblastoma | 1 | 2000 | 24 | 0.180 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2011 | 4058 | 0.180 |
Why?
|
| Image Processing, Computer-Assisted | 8 | 2011 | 8998 | 0.180 |
Why?
|
| Brain | 14 | 2011 | 27101 | 0.180 |
Why?
|
| Urinary Tract Infections | 4 | 2011 | 802 | 0.170 |
Why?
|
| Hernia, Umbilical | 1 | 2001 | 102 | 0.170 |
Why?
|
| Heart Diseases | 3 | 2011 | 2778 | 0.170 |
Why?
|
| Fractures, Bone | 6 | 2007 | 2044 | 0.170 |
Why?
|
| Furosemide | 1 | 2000 | 170 | 0.170 |
Why?
|
| Infant, Newborn | 24 | 2012 | 26180 | 0.160 |
Why?
|
| Pelvis | 1 | 2003 | 732 | 0.160 |
Why?
|
| Sugar Acids | 2 | 1997 | 24 | 0.160 |
Why?
|
| Practice Guidelines as Topic | 3 | 2014 | 7389 | 0.160 |
Why?
|
| Gastric Emptying | 3 | 2000 | 243 | 0.160 |
Why?
|
| Growth Disorders | 1 | 2003 | 634 | 0.160 |
Why?
|
| Technetium | 8 | 1989 | 317 | 0.150 |
Why?
|
| Environmental Exposure | 1 | 2013 | 4483 | 0.150 |
Why?
|
| North America | 3 | 2011 | 1273 | 0.150 |
Why?
|
| Nephroma, Mesoblastic | 1 | 1997 | 24 | 0.150 |
Why?
|
| Spinal Fractures | 1 | 2004 | 704 | 0.150 |
Why?
|
| Testicular Diseases | 1 | 1998 | 73 | 0.150 |
Why?
|
| Technetium Tc 99m Exametazime | 7 | 1996 | 61 | 0.150 |
Why?
|
| Polyamines | 1 | 1998 | 133 | 0.150 |
Why?
|
| Thorax | 3 | 2004 | 555 | 0.150 |
Why?
|
| Child Abuse | 1 | 2007 | 1076 | 0.150 |
Why?
|
| Dancing | 2 | 1997 | 104 | 0.150 |
Why?
|
| Scrotum | 1 | 1998 | 116 | 0.140 |
Why?
|
| Diuretics | 1 | 2000 | 611 | 0.140 |
Why?
|
| Tissue Distribution | 7 | 2012 | 2261 | 0.140 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 1998 | 232 | 0.140 |
Why?
|
| Vaginal Diseases | 1 | 1998 | 103 | 0.140 |
Why?
|
| Mediastinal Neoplasms | 2 | 2002 | 401 | 0.140 |
Why?
|
| Isotopes | 4 | 2004 | 125 | 0.130 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 1996 | 54 | 0.130 |
Why?
|
| Cerebral Ventriculography | 1 | 1996 | 44 | 0.130 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 1997 | 195 | 0.130 |
Why?
|
| Reference Values | 3 | 2012 | 4919 | 0.130 |
Why?
|
| Cerebrovascular Circulation | 5 | 1997 | 2726 | 0.130 |
Why?
|
| Xenon Radioisotopes | 2 | 2011 | 33 | 0.130 |
Why?
|
| Software | 5 | 2012 | 4431 | 0.130 |
Why?
|
| Lung | 11 | 2011 | 9998 | 0.130 |
Why?
|
| Rib Fractures | 1 | 1997 | 128 | 0.130 |
Why?
|
| Stomach | 1 | 2000 | 695 | 0.130 |
Why?
|
| Feasibility Studies | 5 | 2013 | 5239 | 0.130 |
Why?
|
| Neoplasm Recurrence, Local | 5 | 2011 | 9277 | 0.120 |
Why?
|
| Thoracic Nerves | 1 | 1994 | 20 | 0.120 |
Why?
|
| Retrospective Studies | 22 | 2014 | 80566 | 0.120 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 1996 | 125 | 0.120 |
Why?
|
| Protein-Losing Enteropathies | 1 | 1994 | 45 | 0.120 |
Why?
|
| Astrocytoma | 2 | 2008 | 774 | 0.120 |
Why?
|
| Sodium Pertechnetate Tc 99m | 6 | 1998 | 54 | 0.120 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 1996 | 169 | 0.120 |
Why?
|
| Sturge-Weber Syndrome | 1 | 1996 | 89 | 0.120 |
Why?
|
| Pneumonia, Aspiration | 1 | 1995 | 145 | 0.120 |
Why?
|
| Sports | 1 | 2001 | 705 | 0.120 |
Why?
|
| Bronchi | 2 | 1995 | 846 | 0.120 |
Why?
|
| Hip | 1 | 1995 | 255 | 0.110 |
Why?
|
| Radiation Injuries | 2 | 2012 | 1189 | 0.110 |
Why?
|
| Biliary Tract | 2 | 2001 | 135 | 0.110 |
Why?
|
| Spinal Neoplasms | 1 | 2000 | 703 | 0.110 |
Why?
|
| Diagnosis, Differential | 10 | 2007 | 12966 | 0.110 |
Why?
|
| Nonlinear Dynamics | 2 | 2012 | 491 | 0.110 |
Why?
|
| Urinary Incontinence | 1 | 1998 | 489 | 0.110 |
Why?
|
| Kidney Diseases, Cystic | 1 | 1995 | 183 | 0.110 |
Why?
|
| Acute Disease | 6 | 2002 | 7237 | 0.100 |
Why?
|
| Cerebrospinal Fluid | 1 | 1996 | 544 | 0.100 |
Why?
|
| Social Marketing | 1 | 2012 | 52 | 0.100 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2013 | 105 | 0.100 |
Why?
|
| Gait | 1 | 1998 | 811 | 0.100 |
Why?
|
| Hypertension, Renovascular | 1 | 1993 | 116 | 0.100 |
Why?
|
| Fever of Unknown Origin | 1 | 1993 | 94 | 0.100 |
Why?
|
| Epilepsies, Partial | 1 | 1996 | 431 | 0.100 |
Why?
|
| Bone Transplantation | 1 | 1997 | 927 | 0.100 |
Why?
|
| Technetium Compounds | 1 | 2011 | 15 | 0.100 |
Why?
|
| Transposition of Great Vessels | 2 | 1994 | 580 | 0.100 |
Why?
|
| Renal Artery Obstruction | 1 | 1993 | 219 | 0.100 |
Why?
|
| Algorithms | 7 | 2011 | 14018 | 0.100 |
Why?
|
| Bronchodilator Agents | 1 | 1995 | 512 | 0.100 |
Why?
|
| Technetium Tc 99m Sestamibi | 4 | 1994 | 174 | 0.100 |
Why?
|
| Malignant Hyperthermia | 1 | 2011 | 71 | 0.100 |
Why?
|
| Whole-Body Counting | 1 | 2011 | 36 | 0.100 |
Why?
|
| Immunoconjugates | 2 | 2010 | 951 | 0.100 |
Why?
|
| Flumazenil | 1 | 2011 | 84 | 0.090 |
Why?
|
| Iodine Radioisotopes | 2 | 2011 | 1031 | 0.090 |
Why?
|
| Saliva | 1 | 1995 | 828 | 0.090 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 1994 | 477 | 0.090 |
Why?
|
| Peptides, Cyclic | 1 | 2013 | 392 | 0.090 |
Why?
|
| GABA Modulators | 1 | 2011 | 109 | 0.090 |
Why?
|
| Dideoxynucleosides | 1 | 2011 | 135 | 0.090 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2011 | 181 | 0.090 |
Why?
|
| Calcinosis | 2 | 1996 | 1469 | 0.090 |
Why?
|
| Communication | 3 | 2014 | 3849 | 0.090 |
Why?
|
| Integrin beta Chains | 1 | 2010 | 115 | 0.090 |
Why?
|
| Immobilization | 1 | 2011 | 229 | 0.090 |
Why?
|
| Consensus | 3 | 2011 | 3117 | 0.090 |
Why?
|
| Angioplasty, Balloon | 2 | 1996 | 589 | 0.090 |
Why?
|
| Hip Joint | 2 | 1998 | 1014 | 0.080 |
Why?
|
| Societies, Medical | 2 | 2012 | 3900 | 0.080 |
Why?
|
| Thallium | 1 | 1989 | 100 | 0.080 |
Why?
|
| Automation | 1 | 2012 | 585 | 0.080 |
Why?
|
| Adipocytes, Brown | 1 | 2010 | 150 | 0.080 |
Why?
|
| Mandibular Condyle | 1 | 2009 | 115 | 0.080 |
Why?
|
| Drug Labeling | 1 | 2011 | 248 | 0.080 |
Why?
|
| Patient Advocacy | 1 | 2011 | 360 | 0.080 |
Why?
|
| Chelating Agents | 1 | 2010 | 387 | 0.080 |
Why?
|
| Glioma | 3 | 2014 | 3453 | 0.080 |
Why?
|
| Clinical Competence | 2 | 2011 | 4789 | 0.080 |
Why?
|
| Thymus Neoplasms | 1 | 2011 | 274 | 0.080 |
Why?
|
| Meckel Diverticulum | 2 | 1998 | 32 | 0.080 |
Why?
|
| Brain Stem Neoplasms | 1 | 2011 | 190 | 0.080 |
Why?
|
| Pleura | 2 | 2002 | 244 | 0.080 |
Why?
|
| Safety | 1 | 2013 | 1149 | 0.080 |
Why?
|
| Half-Life | 2 | 2000 | 650 | 0.080 |
Why?
|
| Exercise Tolerance | 1 | 1994 | 836 | 0.080 |
Why?
|
| Adult | 27 | 2014 | 220969 | 0.080 |
Why?
|
| Education | 1 | 2011 | 534 | 0.080 |
Why?
|
| Young Adult | 7 | 2012 | 59179 | 0.080 |
Why?
|
| Whole Body Imaging | 1 | 2010 | 283 | 0.080 |
Why?
|
| Thyroid Diseases | 1 | 1992 | 386 | 0.080 |
Why?
|
| Child Behavior Disorders | 1 | 1993 | 804 | 0.080 |
Why?
|
| Radiotherapy Dosage | 2 | 2013 | 2897 | 0.080 |
Why?
|
| Aminohippuric Acids | 1 | 1987 | 8 | 0.070 |
Why?
|
| Radiographic Image Enhancement | 1 | 2012 | 876 | 0.070 |
Why?
|
| p-Aminohippuric Acid | 1 | 1987 | 36 | 0.070 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 1988 | 75 | 0.070 |
Why?
|
| Urography | 4 | 2010 | 316 | 0.070 |
Why?
|
| Cross-Linking Reagents | 1 | 2010 | 685 | 0.070 |
Why?
|
| Area Under Curve | 1 | 2011 | 1635 | 0.070 |
Why?
|
| Thermoluminescent Dosimetry | 1 | 2007 | 27 | 0.070 |
Why?
|
| Organizations | 1 | 2008 | 171 | 0.070 |
Why?
|
| Seasons | 2 | 2010 | 1518 | 0.070 |
Why?
|
| Risk | 3 | 2014 | 9604 | 0.070 |
Why?
|
| Organ Size | 1 | 2012 | 2252 | 0.070 |
Why?
|
| Logistic Models | 3 | 2011 | 13245 | 0.070 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1996 | 1158 | 0.070 |
Why?
|
| Kidney Transplantation | 2 | 1999 | 4236 | 0.070 |
Why?
|
| Necrosis | 1 | 2011 | 1610 | 0.070 |
Why?
|
| Conscious Sedation | 1 | 2011 | 531 | 0.070 |
Why?
|
| Erythroblastosis, Fetal | 1 | 1987 | 62 | 0.070 |
Why?
|
| Radiology Information Systems | 1 | 2011 | 529 | 0.070 |
Why?
|
| Colon | 1 | 1994 | 1791 | 0.070 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 1988 | 296 | 0.070 |
Why?
|
| Reproducibility of Results | 5 | 2011 | 20074 | 0.070 |
Why?
|
| Temperature | 2 | 2010 | 2223 | 0.070 |
Why?
|
| Ultrasonography | 4 | 2011 | 5964 | 0.070 |
Why?
|
| Myocardium | 3 | 2012 | 4724 | 0.070 |
Why?
|
| Aniline Compounds | 2 | 2010 | 1068 | 0.070 |
Why?
|
| Thyroid Gland | 2 | 1992 | 1170 | 0.060 |
Why?
|
| Cerebellar Neoplasms | 1 | 1990 | 586 | 0.060 |
Why?
|
| Leg Injuries | 3 | 1997 | 179 | 0.060 |
Why?
|
| Anisotropy | 1 | 2009 | 1283 | 0.060 |
Why?
|
| Angiocardiography | 1 | 1985 | 149 | 0.060 |
Why?
|
| Ileum | 1 | 1987 | 557 | 0.060 |
Why?
|
| Time Factors | 9 | 2013 | 39913 | 0.060 |
Why?
|
| Spermatic Cord Torsion | 3 | 1999 | 72 | 0.060 |
Why?
|
| Arthritis, Infectious | 3 | 1998 | 347 | 0.060 |
Why?
|
| Pulmonary Embolism | 1 | 1998 | 2568 | 0.060 |
Why?
|
| Rats | 7 | 2012 | 23717 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 2849 | 0.060 |
Why?
|
| Age Factors | 5 | 2013 | 18381 | 0.060 |
Why?
|
| Urodynamics | 2 | 2003 | 344 | 0.060 |
Why?
|
| Sternum | 1 | 1985 | 175 | 0.060 |
Why?
|
| Molecular Imaging | 1 | 2011 | 814 | 0.060 |
Why?
|
| Moyamoya Disease | 2 | 1998 | 265 | 0.060 |
Why?
|
| Radiography | 4 | 2003 | 6961 | 0.060 |
Why?
|
| Cumulative Trauma Disorders | 2 | 2001 | 151 | 0.060 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2011 | 1222 | 0.060 |
Why?
|
| Nitriles | 1 | 1989 | 971 | 0.060 |
Why?
|
| Body Size | 1 | 2007 | 463 | 0.060 |
Why?
|
| Anesthesia, General | 1 | 2011 | 1173 | 0.060 |
Why?
|
| Gallbladder Emptying | 1 | 2003 | 14 | 0.060 |
Why?
|
| Acalculous Cholecystitis | 1 | 2003 | 8 | 0.060 |
Why?
|
| Corn Oil | 1 | 2003 | 28 | 0.060 |
Why?
|
| Aging | 4 | 2011 | 8699 | 0.050 |
Why?
|
| Remission, Spontaneous | 2 | 2001 | 384 | 0.050 |
Why?
|
| Myocardial Ischemia | 1 | 1994 | 2110 | 0.050 |
Why?
|
| Mediastinum | 1 | 2004 | 266 | 0.050 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2003 | 163 | 0.050 |
Why?
|
| Abscess | 2 | 2002 | 606 | 0.050 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2003 | 101 | 0.050 |
Why?
|
| Electroencephalography | 5 | 2004 | 6237 | 0.050 |
Why?
|
| Adipose Tissue, Brown | 1 | 2008 | 762 | 0.050 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 1 | 2003 | 99 | 0.050 |
Why?
|
| Gadolinium | 2 | 1998 | 959 | 0.050 |
Why?
|
| Licensure | 1 | 2003 | 128 | 0.050 |
Why?
|
| Chemistry, Physical | 1 | 2002 | 154 | 0.050 |
Why?
|
| Fibroma | 1 | 2004 | 190 | 0.050 |
Why?
|
| Chemical Phenomena | 1 | 2002 | 506 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2007 | 1700 | 0.050 |
Why?
|
| Animals | 20 | 2013 | 168201 | 0.050 |
Why?
|
| Colitis | 1 | 2010 | 1234 | 0.050 |
Why?
|
| Calcium Channels, L-Type | 1 | 2003 | 242 | 0.050 |
Why?
|
| Maxillofacial Development | 1 | 1982 | 87 | 0.050 |
Why?
|
| Lumbosacral Region | 1 | 2003 | 293 | 0.050 |
Why?
|
| Infant, Premature | 1 | 2011 | 2107 | 0.050 |
Why?
|
| Urinalysis | 1 | 2003 | 368 | 0.050 |
Why?
|
| Follow-Up Studies | 11 | 2003 | 39063 | 0.050 |
Why?
|
| Photomicrography | 1 | 2000 | 71 | 0.050 |
Why?
|
| Kidney Neoplasms | 1 | 1997 | 4250 | 0.050 |
Why?
|
| Infant, Premature, Diseases | 1 | 1987 | 710 | 0.050 |
Why?
|
| Artifacts | 2 | 2007 | 1910 | 0.050 |
Why?
|
| Melanoma | 2 | 2010 | 5697 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 1996 | 4308 | 0.040 |
Why?
|
| Bone Development | 1 | 2003 | 470 | 0.040 |
Why?
|
| Methotrexate | 1 | 1987 | 1716 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2013 | 3599 | 0.040 |
Why?
|
| Pulmonary Circulation | 3 | 1995 | 737 | 0.040 |
Why?
|
| Blood Transfusion | 1 | 1987 | 1299 | 0.040 |
Why?
|
| Professional Competence | 1 | 2003 | 431 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2011 | 23972 | 0.040 |
Why?
|
| Synovitis | 2 | 1998 | 217 | 0.040 |
Why?
|
| Hospitals | 1 | 2013 | 3877 | 0.040 |
Why?
|
| Infant Food | 1 | 2000 | 139 | 0.040 |
Why?
|
| Orchitis | 2 | 1998 | 35 | 0.040 |
Why?
|
| Epididymitis | 2 | 1998 | 37 | 0.040 |
Why?
|
| Gastroesophageal Reflux | 3 | 1992 | 821 | 0.040 |
Why?
|
| Lung Neoplasms | 2 | 2011 | 13382 | 0.040 |
Why?
|
| Connective Tissue Diseases | 1 | 2002 | 285 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2011 | 8516 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2010 | 3031 | 0.040 |
Why?
|
| Fluorescence | 2 | 2012 | 756 | 0.040 |
Why?
|
| Health Promotion | 1 | 2011 | 2206 | 0.040 |
Why?
|
| Pentagastrin | 1 | 1978 | 17 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 2 | 1990 | 2178 | 0.040 |
Why?
|
| Inhalation | 1 | 1979 | 143 | 0.040 |
Why?
|
| Gastric Mucosa | 2 | 1998 | 603 | 0.040 |
Why?
|
| Streptokinase | 1 | 1998 | 186 | 0.040 |
Why?
|
| Liver Diseases | 1 | 1987 | 1297 | 0.040 |
Why?
|
| Neoplasm Staging | 3 | 2008 | 11116 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2011 | 3533 | 0.040 |
Why?
|
| Cations, Divalent | 1 | 1998 | 168 | 0.040 |
Why?
|
| Least-Squares Analysis | 1 | 1999 | 368 | 0.040 |
Why?
|
| Nebulizers and Vaporizers | 1 | 1999 | 139 | 0.040 |
Why?
|
| HIV Seronegativity | 1 | 1999 | 211 | 0.040 |
Why?
|
| Rabbits | 3 | 2003 | 4770 | 0.040 |
Why?
|
| Diseases in Twins | 1 | 2000 | 446 | 0.040 |
Why?
|
| Drug Stability | 1 | 1998 | 291 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2003 | 1152 | 0.040 |
Why?
|
| Photons | 2 | 2012 | 589 | 0.040 |
Why?
|
| Administration, Inhalation | 2 | 1999 | 1156 | 0.040 |
Why?
|
| Radiology | 1 | 2011 | 2113 | 0.040 |
Why?
|
| Gastrostomy | 1 | 2000 | 323 | 0.040 |
Why?
|
| Computer Systems | 1 | 1999 | 469 | 0.040 |
Why?
|
| Parents | 1 | 2011 | 3563 | 0.040 |
Why?
|
| Biological Transport | 2 | 2013 | 2089 | 0.040 |
Why?
|
| Bone Remodeling | 1 | 2001 | 581 | 0.040 |
Why?
|
| Lymph Nodes | 2 | 2012 | 3461 | 0.040 |
Why?
|
| Cohort Studies | 3 | 2013 | 41457 | 0.030 |
Why?
|
| Isotope Labeling | 1 | 1998 | 392 | 0.030 |
Why?
|
| Cardiovascular System | 1 | 2004 | 834 | 0.030 |
Why?
|
| Posture | 1 | 2001 | 956 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 10754 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 2000 | 767 | 0.030 |
Why?
|
| Hodgkin Disease | 1 | 2004 | 1378 | 0.030 |
Why?
|
| Aerosols | 1 | 1999 | 635 | 0.030 |
Why?
|
| Asthma | 1 | 1995 | 6233 | 0.030 |
Why?
|
| Ion Exchange Resins | 1 | 1995 | 7 | 0.030 |
Why?
|
| Silica Gel | 1 | 1995 | 4 | 0.030 |
Why?
|
| Infusions, Intravenous | 2 | 1999 | 2214 | 0.030 |
Why?
|
| Mothers | 1 | 2007 | 2194 | 0.030 |
Why?
|
| Mice | 9 | 2013 | 81368 | 0.030 |
Why?
|
| Radiochemistry | 1 | 1995 | 49 | 0.030 |
Why?
|
| Methods | 3 | 1986 | 1065 | 0.030 |
Why?
|
| Predictive Value of Tests | 4 | 2011 | 15251 | 0.030 |
Why?
|
| Technetium Tc 99m Aggregated Albumin | 1 | 1995 | 66 | 0.030 |
Why?
|
| Models, Biological | 1 | 2011 | 9461 | 0.030 |
Why?
|
| Urinary Bladder, Neurogenic | 1 | 1996 | 173 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2011 | 10432 | 0.030 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 1996 | 164 | 0.030 |
Why?
|
| Ligands | 1 | 2002 | 3268 | 0.030 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 1995 | 202 | 0.030 |
Why?
|
| Anastomosis, Surgical | 1 | 1998 | 982 | 0.030 |
Why?
|
| Mass Screening | 1 | 2010 | 5424 | 0.030 |
Why?
|
| Silicon Dioxide | 1 | 1995 | 216 | 0.030 |
Why?
|
| Prospective Studies | 5 | 2000 | 54360 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 6126 | 0.030 |
Why?
|
| Observer Variation | 1 | 2000 | 2606 | 0.030 |
Why?
|
| Radiation | 1 | 1994 | 49 | 0.030 |
Why?
|
| Enteral Nutrition | 1 | 2000 | 794 | 0.030 |
Why?
|
| Radionuclide Angiography | 1 | 1993 | 22 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 1998 | 1835 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2010 | 9172 | 0.030 |
Why?
|
| HIV Seropositivity | 1 | 1999 | 959 | 0.030 |
Why?
|
| Eating | 1 | 2000 | 1535 | 0.030 |
Why?
|
| Physicians | 1 | 2011 | 4583 | 0.030 |
Why?
|
| Spinal Diseases | 1 | 1998 | 561 | 0.030 |
Why?
|
| Glycols | 1 | 2012 | 55 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2001 | 4804 | 0.030 |
Why?
|
| Pulmonary Veins | 1 | 1998 | 716 | 0.030 |
Why?
|
| Fluorocarbons | 1 | 1998 | 492 | 0.030 |
Why?
|
| Diagnostic Techniques, Urological | 1 | 2012 | 27 | 0.030 |
Why?
|
| Postoperative Complications | 6 | 1998 | 15612 | 0.030 |
Why?
|
| Domperidone | 1 | 1992 | 24 | 0.030 |
Why?
|
| Respiration | 1 | 1979 | 1656 | 0.030 |
Why?
|
| HIV Infections | 1 | 1999 | 17337 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 1998 | 2231 | 0.020 |
Why?
|
| Phenylketonurias | 1 | 1993 | 126 | 0.020 |
Why?
|
| Exercise Test | 2 | 2004 | 2127 | 0.020 |
Why?
|
| Ventilation-Perfusion Ratio | 3 | 1985 | 117 | 0.020 |
Why?
|
| Thyroglossal Cyst | 1 | 1991 | 31 | 0.020 |
Why?
|
| Esters | 1 | 2012 | 211 | 0.020 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 1999 | 1351 | 0.020 |
Why?
|
| Neoplasms | 2 | 2011 | 22131 | 0.020 |
Why?
|
| Life Expectancy | 1 | 1998 | 1239 | 0.020 |
Why?
|
| Medical Staff | 1 | 2011 | 40 | 0.020 |
Why?
|
| Renal Artery | 1 | 1993 | 351 | 0.020 |
Why?
|
| Infrared Rays | 1 | 2012 | 247 | 0.020 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 1994 | 574 | 0.020 |
Why?
|
| Pentetic Acid | 2 | 1990 | 209 | 0.020 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2003 | 2223 | 0.020 |
Why?
|
| Radioimmunodetection | 1 | 2010 | 45 | 0.020 |
Why?
|
| Hydrocephalus | 1 | 1997 | 764 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2011 | 12447 | 0.020 |
Why?
|
| Aphasia | 1 | 1992 | 192 | 0.020 |
Why?
|
| Electrons | 1 | 2012 | 265 | 0.020 |
Why?
|
| Inflammation | 1 | 2010 | 10760 | 0.020 |
Why?
|
| Recurrence | 2 | 2008 | 8426 | 0.020 |
Why?
|
| Heterocyclic Compounds, 1-Ring | 1 | 2010 | 68 | 0.020 |
Why?
|
| Psychophysics | 1 | 2011 | 292 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2003 | 8618 | 0.020 |
Why?
|
| Movement Disorders | 1 | 1994 | 459 | 0.020 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1995 | 732 | 0.020 |
Why?
|
| Laboratories | 1 | 1994 | 458 | 0.020 |
Why?
|
| Contrast Media | 3 | 2000 | 5305 | 0.020 |
Why?
|
| Liver | 2 | 2001 | 7512 | 0.020 |
Why?
|
| Cell Line, Tumor | 3 | 2013 | 16967 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 1996 | 1302 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 1 | 2010 | 361 | 0.020 |
Why?
|
| Leg | 1 | 1994 | 1087 | 0.020 |
Why?
|
| Trachea | 1 | 1995 | 1089 | 0.020 |
Why?
|
| Heterocyclic Compounds | 1 | 2010 | 245 | 0.020 |
Why?
|
| Dextran Sulfate | 1 | 2010 | 258 | 0.020 |
Why?
|
| Spirometry | 1 | 1973 | 928 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 1998 | 2055 | 0.020 |
Why?
|
| Body Height | 1 | 1996 | 1565 | 0.020 |
Why?
|
| Relative Biological Effectiveness | 1 | 2010 | 311 | 0.020 |
Why?
|
| Fibrinolytic Agents | 1 | 1998 | 2073 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 1994 | 1515 | 0.020 |
Why?
|
| Pulmonary Surfactants | 1 | 1989 | 162 | 0.020 |
Why?
|
| Imino Acids | 1 | 1988 | 19 | 0.020 |
Why?
|
| Quality Control | 1 | 2011 | 831 | 0.020 |
Why?
|
| Hospitalization | 1 | 2008 | 10704 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 4947 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2012 | 683 | 0.020 |
Why?
|
| Hemodynamics | 3 | 1997 | 4160 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 2 | 2011 | 5491 | 0.020 |
Why?
|
| Iodohippuric Acid | 1 | 1987 | 9 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2008 | 22148 | 0.020 |
Why?
|
| Biliary Atresia | 1 | 1988 | 88 | 0.020 |
Why?
|
| Operating Rooms | 1 | 1994 | 789 | 0.020 |
Why?
|
| Echocardiography | 2 | 2004 | 4987 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2012 | 3074 | 0.020 |
Why?
|
| Reference Standards | 1 | 2011 | 1002 | 0.020 |
Why?
|
| DNA Primers | 1 | 2011 | 2817 | 0.020 |
Why?
|
| Blood Transfusion, Intrauterine | 1 | 1987 | 28 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 1994 | 1474 | 0.020 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 1989 | 233 | 0.020 |
Why?
|
| Markov Chains | 1 | 2010 | 965 | 0.020 |
Why?
|
| Pulmonary Artery | 3 | 1996 | 1927 | 0.020 |
Why?
|
| Mutation | 1 | 2011 | 30016 | 0.020 |
Why?
|
| Cardiac Output | 2 | 1990 | 831 | 0.020 |
Why?
|
| Exercise | 1 | 2003 | 5886 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 1997 | 4910 | 0.020 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2008 | 326 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2010 | 22115 | 0.020 |
Why?
|
| Siblings | 1 | 2010 | 824 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2003 | 7847 | 0.020 |
Why?
|
| Fluoroscopy | 1 | 2010 | 945 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2008 | 957 | 0.020 |
Why?
|
| Tracheoesophageal Fistula | 1 | 1987 | 131 | 0.020 |
Why?
|
| Survival Analysis | 1 | 1998 | 10073 | 0.020 |
Why?
|
| Syndrome | 2 | 1992 | 3268 | 0.020 |
Why?
|
| Linear Models | 1 | 1996 | 5866 | 0.020 |
Why?
|
| Species Specificity | 1 | 2010 | 2411 | 0.020 |
Why?
|
| Exons | 1 | 2011 | 2381 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2010 | 1185 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 1996 | 2637 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2010 | 1964 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2011 | 990 | 0.020 |
Why?
|
| Intraoperative Period | 1 | 1986 | 510 | 0.010 |
Why?
|
| User-Computer Interface | 1 | 2011 | 1397 | 0.010 |
Why?
|
| Pain | 2 | 1998 | 5061 | 0.010 |
Why?
|
| Esophageal Atresia | 1 | 1987 | 225 | 0.010 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2004 | 61 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 1988 | 1096 | 0.010 |
Why?
|
| Seizures | 1 | 1997 | 2954 | 0.010 |
Why?
|
| Medical Informatics | 1 | 2011 | 732 | 0.010 |
Why?
|
| Fever | 1 | 2011 | 1618 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2007 | 2010 | 0.010 |
Why?
|
| Mathematics | 1 | 1985 | 707 | 0.010 |
Why?
|
| Anesthesiology | 1 | 1994 | 1120 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2011 | 2423 | 0.010 |
Why?
|
| Blood Volume | 1 | 1985 | 547 | 0.010 |
Why?
|
| Middle Aged | 6 | 2011 | 220584 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2007 | 794 | 0.010 |
Why?
|
| Occupational Exposure | 1 | 1994 | 1813 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2007 | 1878 | 0.010 |
Why?
|
| Dopamine | 1 | 1990 | 1606 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2013 | 2644 | 0.010 |
Why?
|
| Heart Block | 1 | 2004 | 384 | 0.010 |
Why?
|
| Visual Perception | 1 | 2011 | 1388 | 0.010 |
Why?
|
| Swine | 1 | 2012 | 5907 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2012 | 18221 | 0.010 |
Why?
|
| Multifactorial Inheritance | 1 | 2010 | 1380 | 0.010 |
Why?
|
| Dogs | 1 | 1987 | 3838 | 0.010 |
Why?
|
| Tachycardia | 1 | 2004 | 597 | 0.010 |
Why?
|
| Gallbladder | 1 | 2003 | 308 | 0.010 |
Why?
|
| Esophagus | 1 | 1987 | 1031 | 0.010 |
Why?
|
| Age Determination by Skeleton | 1 | 1982 | 126 | 0.010 |
Why?
|
| COS Cells | 1 | 2003 | 1130 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 2011 | 1998 | 0.010 |
Why?
|
| Prognosis | 3 | 2011 | 29600 | 0.010 |
Why?
|
| Cholecystectomy | 1 | 2003 | 406 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2011 | 2315 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 1994 | 3873 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2010 | 2821 | 0.010 |
Why?
|
| Spleen | 1 | 1987 | 2286 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 1989 | 0.010 |
Why?
|
| Incidence | 2 | 1997 | 21337 | 0.010 |
Why?
|
| Twins, Dizygotic | 1 | 2000 | 236 | 0.010 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2004 | 709 | 0.010 |
Why?
|
| United States | 2 | 2007 | 72272 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 2747 | 0.010 |
Why?
|
| Thoracic Surgery | 1 | 1985 | 722 | 0.010 |
Why?
|
| Heart Conduction System | 1 | 2004 | 992 | 0.010 |
Why?
|
| Kinetics | 1 | 1986 | 6370 | 0.010 |
Why?
|
| Barium Sulfate | 1 | 1979 | 180 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 1 | 1994 | 3621 | 0.010 |
Why?
|
| Swine, Miniature | 1 | 2000 | 961 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2012 | 6233 | 0.010 |
Why?
|
| Thyroid Neoplasms | 1 | 1992 | 2332 | 0.010 |
Why?
|
| Twins, Monozygotic | 1 | 2000 | 470 | 0.010 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 1993 | 3708 | 0.010 |
Why?
|
| Reaction Time | 1 | 2004 | 2087 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 4172 | 0.010 |
Why?
|
| DNA | 1 | 2011 | 7196 | 0.010 |
Why?
|
| Heptoses | 1 | 1977 | 8 | 0.010 |
Why?
|
| Heart Rate | 2 | 2004 | 4180 | 0.010 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2004 | 1493 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 8542 | 0.010 |
Why?
|
| Chronic Disease | 2 | 2003 | 9311 | 0.010 |
Why?
|
| Succinates | 1 | 1977 | 81 | 0.010 |
Why?
|
| Diphosphonates | 1 | 1982 | 635 | 0.010 |
Why?
|
| Abdominal Pain | 1 | 2003 | 1070 | 0.010 |
Why?
|
| Aged | 3 | 2011 | 169042 | 0.010 |
Why?
|
| Histological Techniques | 1 | 1977 | 194 | 0.010 |
Why?
|
| Heart Valve Diseases | 1 | 2004 | 1028 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2004 | 1779 | 0.010 |
Why?
|
| Thoracotomy | 1 | 1998 | 366 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2011 | 6561 | 0.010 |
Why?
|
| Milk | 1 | 1979 | 442 | 0.010 |
Why?
|
| Autoradiography | 1 | 1977 | 728 | 0.010 |
Why?
|
| Risk Factors | 2 | 2010 | 74115 | 0.010 |
Why?
|
| Osteonecrosis | 1 | 1998 | 229 | 0.010 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 1996 | 109 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2003 | 64568 | 0.010 |
Why?
|
| Respiratory System | 1 | 1979 | 563 | 0.010 |
Why?
|
| Electrocardiography | 2 | 2004 | 6346 | 0.010 |
Why?
|
| Sheep | 1 | 1998 | 1436 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 1998 | 652 | 0.010 |
Why?
|
| Stroke Volume | 2 | 1986 | 5486 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2003 | 6188 | 0.010 |
Why?
|
| Gadolinium DTPA | 1 | 1997 | 823 | 0.010 |
Why?
|
| Survival Rate | 1 | 2008 | 12719 | 0.010 |
Why?
|
| Disease Progression | 1 | 2011 | 13495 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 6520 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 1990 | 4671 | 0.010 |
Why?
|
| Cardiomyopathies | 1 | 1985 | 1948 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1998 | 2668 | 0.010 |
Why?
|
| Xenon | 1 | 1973 | 112 | 0.010 |
Why?
|
| Apraxias | 1 | 1992 | 59 | 0.010 |
Why?
|
| Base Sequence | 1 | 2003 | 12421 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2003 | 3608 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 7402 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 13441 | 0.010 |
Why?
|
| Spondylolysis | 1 | 1991 | 46 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2007 | 3426 | 0.010 |
Why?
|
| Age Distribution | 1 | 1997 | 2871 | 0.010 |
Why?
|
| Videotape Recording | 1 | 1973 | 338 | 0.010 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1998 | 1116 | 0.010 |
Why?
|
| Sclerosis | 1 | 1991 | 210 | 0.010 |
Why?
|
| Magnetic Resonance Angiography | 1 | 1997 | 1431 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 17629 | 0.010 |
Why?
|
| Prolactin | 1 | 1992 | 625 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 17878 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2010 | 26049 | 0.010 |
Why?
|
| Age of Onset | 1 | 1996 | 3302 | 0.000 |
Why?
|
| Fatigue | 1 | 1996 | 1550 | 0.000 |
Why?
|
| Urine | 1 | 1990 | 362 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 2003 | 12758 | 0.000 |
Why?
|
| Dyspnea | 1 | 1996 | 1347 | 0.000 |
Why?
|
| Oxygen | 2 | 1990 | 4226 | 0.000 |
Why?
|
| Oxalates | 1 | 1987 | 97 | 0.000 |
Why?
|
| Vascular Resistance | 1 | 1990 | 930 | 0.000 |
Why?
|
| Metatarsal Bones | 1 | 1988 | 110 | 0.000 |
Why?
|
| Neutropenia | 1 | 1992 | 885 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1987 | 11736 | 0.000 |
Why?
|
| Carbon Dioxide | 1 | 1990 | 1148 | 0.000 |
Why?
|
| Fibula | 1 | 1988 | 266 | 0.000 |
Why?
|
| Esophagoscopy | 1 | 1987 | 397 | 0.000 |
Why?
|
| Diarrhea | 1 | 1992 | 1317 | 0.000 |
Why?
|
| Manometry | 1 | 1987 | 454 | 0.000 |
Why?
|
| Temporal Lobe | 1 | 1992 | 1695 | 0.000 |
Why?
|
| Ankle Injuries | 1 | 1988 | 338 | 0.000 |
Why?
|
| Quality of Life | 1 | 2004 | 13347 | 0.000 |
Why?
|
| Respiratory Function Tests | 1 | 1987 | 1683 | 0.000 |
Why?
|
| Neuropsychological Tests | 1 | 1995 | 7050 | 0.000 |
Why?
|
| Stress, Mechanical | 1 | 1987 | 1674 | 0.000 |
Why?
|
| Weight Gain | 1 | 1992 | 2350 | 0.000 |
Why?
|
| Testis | 1 | 1985 | 792 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 1997 | 15828 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1992 | 12334 | 0.000 |
Why?
|
| Head and Neck Neoplasms | 1 | 1991 | 2894 | 0.000 |
Why?
|
| Lung Volume Measurements | 1 | 1977 | 375 | 0.000 |
Why?
|
| Hernia, Diaphragmatic | 1 | 1977 | 244 | 0.000 |
Why?
|
| Airway Resistance | 1 | 1977 | 406 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1990 | 8472 | 0.000 |
Why?
|
| Atrophy | 1 | 1977 | 1631 | 0.000 |
Why?
|